Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-09

Clinical Trial Update: Lamotrigine in Reducing Psychologic Side-Effect of Perioperative Ketamine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lamotrigine to reduce psychological side effects of perioperative ketamine has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Reducing Psychological Side Effects of Ketamine | Phase 3 | Status: COMPLETED | Results posted: 2021-06-09